ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,180, issued on April 22, was assigned to New York University (New York).

"Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same" was invented by Kent Kirshenbaum (New York), Susan Logan (New York), Timothy Craven (Seattle), Amanda Kasper (New York), Richard A. Bonneau (New York) and Jeffrey A Schneider (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are peptoid-peptide macrocycles. The peptoid-peptide macrocycles may have inhibitory activity towards the Wnt signaling pathway. The Wnt signaling pathway is associated with cancer and other diseases and conditions. Such diseases include, for example, pul...